title: Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
authors.forename: J
authors.initials: J
authors.lastname: Dalmau
authors.forename: L
authors.initials: L
authors.lastname: Peramiquel
authors.forename: L
authors.initials: L
authors.lastname: Puig
authors.forename: M T
authors.initials: MT
authors.lastname: Fernández-Figueras
authors.forename: E
authors.initials: E
authors.lastname: Roé
authors.forename: A
authors.initials: A
authors.lastname: Alomar
mesh_terms: D017255:Acitretin / Q000627:therapeutic use*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D000068877:Imatinib Mesylate; D007641:Keratolytic Agents / Q000627:therapeutic use; D017512:Lichenoid Eruptions / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D007641:Keratolytic Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D017255:Acitretin